Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Autoria(s): Hogendoorn P.C.; ESMO/EUROBONET Working Group; Athanasou N.; Athanasou N.; Bielack S.; De Alava E.; Dei Tos A.P.; Ferrari S.; Gelderblom H.; Grimer R.; Hall K.S.; Hassan B.; Hogendoorn P.C.; Jurgens H.; Paulussen M.; Rozeman L.; Taminiau A.H.; Whelan J.; Vanel D.
Data(s)

2010
Identificador

https://serval.unil.ch/?id=serval:BIB_25302DBE44E9

isbn:1569-8041 (Electronic)

pmid:20555083

doi:10.1093/annonc/mdq223

isiid:000278968900043
Idioma(s)

en
Fonte

Annals of Oncology, vol. 21 Suppl 5, no. Suppl. 5, pp. v204-v213
Palavras-Chave #Adolescent; Alkaline Phosphatase/blood; Antigens, CD/blood; Biopsy; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Europe/epidemiology; Female; Follow-Up Studies; Humans; Incidence; L-Lactate Dehydrogenase/blood; Male; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma/diagnosis; Osteosarcoma/pathology; Periodic Acid-Schiff Reaction; Prognosis; Radiotherapy; Recurrence/prevention & control; Risk Assessment; Treatment Outcome
Tipo

info:eu-repo/semantics/review

article
Acesso ao item digital